Panacea Life Sciences Holdings, Inc.
PLSH
$0.0539
$0.005912.29%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -88.27% | -89.60% | -93.07% | -81.97% | -65.61% |
| Total Receivables | -65.04% | -62.61% | 12.04% | 7.30% | 16.93% |
| Inventory | -0.79% | -9.78% | 6.34% | -2.74% | -5.31% |
| Prepaid Expenses | 144.71% | 132.54% | 48.23% | -53.37% | -66.40% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -21.92% | -27.04% | -9.41% | -29.21% | -26.80% |
|
|
|||||
| Total Current Assets | -21.92% | -27.04% | -9.41% | -29.21% | -26.80% |
| Net Property, Plant & Equipment | -6.39% | -5.55% | -12.85% | -14.71% | -13.53% |
| Long-term Investments | 37.72% | 37.72% | 37.72% | 0.00% | 0.00% |
| Goodwill | 37.72% | 37.72% | 37.72% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -6.17% | -7.73% | -6.26% | -18.72% | -17.19% |
|
|
|||||
| Total Accounts Payable | 68.89% | 73.65% | 70.91% | 30.47% | 42.53% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 80.38% | 13.73% | -84.20% | -79.55% | -71.13% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.58% | 19.64% | 38.06% | 39.18% | 45.54% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 28.33% | 29.02% | 34.17% | 30.49% | 37.49% |
|
|
|||||
| Total Current Liabilities | 28.33% | 29.02% | 34.17% | 30.49% | 37.49% |
| Long-Term Debt | 0.00% | 0.00% | 1.18% | 2.68% | 4.68% |
| Short-term Debt | 80.38% | 13.73% | -84.20% | -79.55% | -71.13% |
| Capital Leases | 6.08% | 8.93% | -12.08% | -11.61% | -11.17% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 20.92% | 21.45% | 21.50% | 18.81% | 22.65% |
|
|
|||||
| Common Stock & APIC | 7.73% | 7.86% | 7.86% | 0.98% | 0.72% |
| Retained Earnings | -27.69% | -30.94% | -31.03% | -37.44% | -41.70% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -153.14% | -286.53% | -1,280.31% | -347.12% | -190.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 33.33% | 33.33% | 77.78% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 33.33% | 33.33% | 77.78% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -153.14% | -286.53% | -1,280.31% | -347.12% | -190.95% |
| Total Preferred Equity | 33.33% | 33.33% | 77.78% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -153.17% | -286.64% | -1,282.77% | -346.98% | -190.91% |
|
|
|||||
